Thank you, Chair, and thank you to our witnesses.
I'm going to start with Dr. Yusuf. I'm very interested in trying to see how we can support having more clinical trials in Canada. I have heard some people say that one of the things that may impact clinical trials is the changes to the PMPRB drug approval process that will make the process longer and take away price certainty, possibly for about three years.
You mentioned that Canada's at 3.3% in its spend on clinical trials, compared to the U.K. and the U.S. at 11%, so of course one obvious action is to put more money in, and that's the amount, but are there other barriers that we should address in order to encourage more clinical trials in Canada?